NLM Logo

magnesium citrate, potassium citrate, pyridoxine HCl, sodium citrate drug combination MeSH Supplementary Concept Data 2024


MeSH Supplementary
magnesium citrate, potassium citrate, pyridoxine HCl, sodium citrate drug combination
Unique ID
C008309
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C008309
Entry Term(s)
Magurlit
magnesium citrate - potassium citrate - pyridoxine HCl - sodium citrate
magurlyt
Registry Number
78090-19-4
CAS Type 1 Name
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mixt. with 5-hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride, 2-hydroxy-1,2,3-propanetricarboxylic acid magnesium salt (1:1), 2-hydroxy-1,2,3-propanetricarboxylic acid tripotassium salt, and 2-hydroxy-1,2,3-propanetricarboxylic acid trisodium salt
Heading Mapped to
*Citrates
Drug Combinations
*Pyridoxine
Frequency
13
Note
combination drug for dissolution of urinary calculi consists of Na,K & Mg citrates & pyridoxine HCl
Source
Int Urol Nephrol 10(3):195;1978
Orv Hetil 115(4):196;1974
Ther Hung 1979;27(3):137
Ther Hung 25(1):27;1977
Indexing Information
Urinary Calculi
Date of Entry
1974/01/01
Revision Date
2013/10/24
magnesium citrate, potassium citrate, pyridoxine HCl, sodium citrate drug combination Preferred
magurlyt Narrower
page delivered in 0.005s